Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Thulliez, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thulliez, P
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Journal of Epidemiology 2001;30:1315-1316
© International Epidemiological Association 2001

Perinatal epidemiology

Commentary: Efficacy of prenatal treatment for toxoplasmosis: a possibility that cannot be ruled out

P Thulliez

Laboratoire de la Toxoplasmose, Institut de Puériculture, Paris, France.

In their retrospective cohort study of 554 mother-child pairs, Gilbert et al. did not detect a significant effect of prenatal treatment on the risk of vertical transmission of toxoplasmosis.1 This result is not surprising as there were very few untreated women and the analysis of no treatment versus pyrimethamine-sulphadiazine was restricted to half of the cohort who . . . [Full Text of this Article]

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?